文献
J-GLOBAL ID:202002219323855020
整理番号:20A0839859
海馬CD39/EntPD1は細胞外ATPの加水分解を介してマウス抑制様行動を促進する【JST・京大機械翻訳】
Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP
著者 (21件):
Cui Qian-Qian
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Hu Zhuang-Li
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Hu Zhuang-Li
(The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan City, China)
,
Hu Zhuang-Li
(Laboratory of Neuropsychiatric Diseases, The Institute of Brain Research, Huazhong University of Science and Technology, Wuhan, China)
,
Hu Zhuang-Li
(The Research Center for Depression, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
,
Hu Yuan-Lang
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Chen Xi
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Wang Ji
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Mao Li
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Lu Xiao-Jia
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Ni Ming
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Chen Jian-Guo
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Chen Jian-Guo
(The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan City, China)
,
Chen Jian-Guo
(Laboratory of Neuropsychiatric Diseases, The Institute of Brain Research, Huazhong University of Science and Technology, Wuhan, China)
,
Chen Jian-Guo
(The Research Center for Depression, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
,
Chen Jian-Guo
(Key Laboratory of Neurological Diseases (HUST), Ministry of Education of China, Wuhan City, China)
,
Wang Fang
(Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China)
,
Wang Fang
(The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan City, China)
,
Wang Fang
(Laboratory of Neuropsychiatric Diseases, The Institute of Brain Research, Huazhong University of Science and Technology, Wuhan, China)
,
Wang Fang
(The Research Center for Depression, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
,
Wang Fang
(Key Laboratory of Neurological Diseases (HUST), Ministry of Education of China, Wuhan City, China)
資料名:
EMBO Reports
(EMBO Reports)
巻:
21
号:
4
ページ:
e47857
発行年:
2020年
JST資料番号:
W1261A
ISSN:
1469-221X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)